Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer
Go back to Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer| CytoDyn, Inc. (AMEX: CYDY) | Delayed: 0.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.26 | 52 Week High | $1.57 | |||
| Open | $0.26 | 52 Week Low | $0.61 | |||
| Day High | $0.26 | P/E | N/A | |||
| Day Low | $0.26 | EPS | $0.00 | |||
| Volume | 3,463 | |||||
| (NASDAQ: NTRA) | Delayed: 228.80 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $228.80 | 52 Week High | $13.80 | |||
| Open | $228.80 | 52 Week Low | $6.52 | |||
| Day High | $228.80 | P/E | N/A | |||
| Day Low | $228.80 | EPS | $0.00 | |||
| Volume | 1,051 | |||||
